Pol Vilain

Title: Pol Vilain: Innovator in Pharmaceutical Formulations

Introduction

Pol Vilain is a notable inventor based in Saussan, France. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications for oral administration. His innovative work has led to the development of a unique patent that addresses specific needs in the pharmaceutical industry.

Latest Patents

Pol Vilain holds a patent for "Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound." This patent includes formulations that contain from 0.5 to 50% by weight of a cyclic quaternary ammonium compound, along with pharmaceutically appropriate excipients. The formulations are created through wet granulation, preferably using polysorbate 80. This innovation is crucial for enhancing the effectiveness and delivery of pharmaceutical compounds.

Career Highlights

Pol Vilain is associated with Sanofi-Synthelabo, a leading global healthcare company. His work at Sanofi-Synthelabo has allowed him to focus on developing advanced pharmaceutical formulations that improve patient outcomes. His dedication to research and development has positioned him as a key player in the pharmaceutical industry.

Collaborations

Pol Vilain has collaborated with esteemed colleagues such as Bernard Abramovici and Xavier Boulenc. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical sector.

Conclusion

Pol Vilain's contributions to pharmaceutical formulations demonstrate his commitment to advancing medical science. His innovative patent and collaborative efforts highlight the importance of teamwork in achieving breakthroughs in healthcare.